These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 37522564)
1. Clinicopathologic Features and Prognostic Significance of Immunohistochemistry and In Situ Hybridization Based Molecular Classification in Gastric Carcinoma. Issin G; Sayar İ; Demir F; Bakkaloğlu İG; Gamsizkan M; Yildiz Z; Yilmaz I; Özmen SA; Çağatay DV; Zemheri IE; Demiriz M; Günal A J Environ Pathol Toxicol Oncol; 2023; 42(4):1-14. PubMed ID: 37522564 [TBL] [Abstract][Full Text] [Related]
2. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors. Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer. Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer. Li LL; Yu AY; Zhu M; Ma LY; Cao MH; Liu WL; Qin XB; Gao C; Han ZX; Wang HM Arch Virol; 2024 May; 169(5):114. PubMed ID: 38700535 [TBL] [Abstract][Full Text] [Related]
5. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients. Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379 [TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer. Yang N; Wu Y; Jin M; Jia Z; Wang Y; Cao D; Qin L; Wang X; Zheng M; Cao X; Jiang J PeerJ; 2021; 9():e11481. PubMed ID: 34046266 [TBL] [Abstract][Full Text] [Related]
7. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases. Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224 [TBL] [Abstract][Full Text] [Related]
8. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability. Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786 [TBL] [Abstract][Full Text] [Related]
9. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery. Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602 [TBL] [Abstract][Full Text] [Related]
10. Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications. Koh J; Lee KW; Nam SK; Seo AN; Kim JW; Kim JW; Park DJ; Kim HH; Kim WH; Lee HS Oncologist; 2019 Dec; 24(12):e1321-e1330. PubMed ID: 31371521 [TBL] [Abstract][Full Text] [Related]
11. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features. Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413 [TBL] [Abstract][Full Text] [Related]
12. Gastric cancer molecular classification based on immunohistochemistry and in-situ hybridisation and mortality. Eskuri M; Birkman EM; Kauppila JH Histopathology; 2024 Aug; 85(2):327-337. PubMed ID: 38715404 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics of Epstein-Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the World Health Organization criteria. Tanabe H; Mizukami Y; Takei H; Tamamura N; Omura Y; Kobayashi Y; Murakami Y; Kunogi T; Sasaki T; Takahashi K; Ando K; Ueno N; Kashima S; Yuzawa S; Hasegawa K; Sumi Y; Tanino M; Fujiya M; Okumura T J Pathol Clin Res; 2021 Jul; 7(4):397-409. PubMed ID: 33750036 [TBL] [Abstract][Full Text] [Related]
15. The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review. Bos J; Groen-van Schooten TS; Brugman CP; Jamaludin FS; van Laarhoven HWM; Derks S Cancer Treat Rev; 2024 Jun; 127():102737. PubMed ID: 38669788 [TBL] [Abstract][Full Text] [Related]
16. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas. Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan. Yoshida T; Ogura G; Tanabe M; Hayashi T; Ohbayashi C; Azuma M; Kunisaki C; Akazawa Y; Ozawa S; Matsumoto S; Suzuki T; Mitoro A; Fukunaga T; Shimizu A; Fujimoto G; Yao T Cancer Biol Ther; 2022 Dec; 23(1):191-200. PubMed ID: 35220884 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients. Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752 [TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma. Kim DH; Bae GE; Suh KS; Ryuman D; Song KS; Kim JS; Lee SI; Yeo MK In Vivo; 2020; 34(6):3171-3180. PubMed ID: 33144421 [TBL] [Abstract][Full Text] [Related]
20. Correlation of microsatellite status and EBV infection with clinical characteristics of patients with gastric cancer. Lu P; Yushan K; Yusufu G; Wang H; Mao R Gen Physiol Biophys; 2023 Sep; 42(5):403-415. PubMed ID: 37702446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]